Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-01-03

FDA Approved: FLUOXETINE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals' supplemental application for fluoxetine hydrochloride.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluoxetine hydrochloride (Fluoxetine hydrochloride)

Snippet

SUPPL AP for FLUOXETINE HYDROCHLORIDE (FLUOXETINE HYDROCHLORIDE)